BRCA2 promotes DNA-RNA hybrid resolution by DDX5 helicase at DNA breaks to facilitate their repair‡.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
01 04 2021
Historique:
revised: 22 01 2021
received: 23 06 2020
accepted: 25 01 2021
pubmed: 27 2 2021
medline: 3 4 2022
entrez: 26 2 2021
Statut: ppublish

Résumé

The BRCA2 tumor suppressor is a DNA double-strand break (DSB) repair factor essential for maintaining genome integrity. BRCA2-deficient cells spontaneously accumulate DNA-RNA hybrids, a known source of genome instability. However, the specific role of BRCA2 on these structures remains poorly understood. Here we identified the DEAD-box RNA helicase DDX5 as a BRCA2-interacting protein. DDX5 associates with DNA-RNA hybrids that form in the vicinity of DSBs, and this association is enhanced by BRCA2. Notably, BRCA2 stimulates the DNA-RNA hybrid-unwinding activity of DDX5 helicase. An impaired BRCA2-DDX5 interaction, as observed in cells expressing the breast cancer variant BRCA2-T207A, reduces the association of DDX5 with DNA-RNA hybrids, decreases the number of RPA foci, and alters the kinetics of appearance of RAD51 foci upon irradiation. Our findings are consistent with DNA-RNA hybrids constituting an impediment for the repair of DSBs by homologous recombination and reveal BRCA2 and DDX5 as active players in their removal.

Identifiants

pubmed: 33634895
doi: 10.15252/embj.2020106018
pmc: PMC8013831
doi:

Substances chimiques

BRCA2 Protein 0
BRCA2 protein, human 0
Nucleic Acid Heteroduplexes 0
Ddx5 protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Banques de données

GEO
['GSE150163']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e106018

Informations de copyright

© 2021 The Authors.

Références

Cell. 2010 Jun 11;141(6):970-81
pubmed: 20550933
Mol Cell. 2001 Feb;7(2):263-72
pubmed: 11239455
Methods Enzymol. 2018;600:479-511
pubmed: 29458771
NAR Cancer. 2020 Sep;2(3):zcaa028
pubmed: 33015627
Cell Rep. 2015 Oct 27;13(4):678-689
pubmed: 26489468
J Proteome Res. 2009 Jul;8(7):3737-45
pubmed: 19385687
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Mol Cell. 2003 Mar;11(3):807-15
pubmed: 12667461
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Genes Dev. 2020 Jul 1;34(13-14):898-912
pubmed: 32439635
Cell Rep. 2018 Jan 23;22(4):1031-1039
pubmed: 29386125
DNA Repair (Amst). 2011 Jun 10;10(6):654-65
pubmed: 21561811
Genes Dev. 2014 Apr 1;28(7):735-48
pubmed: 24636987
Mol Cell. 2013 May 23;50(4):589-600
pubmed: 23706822
Mol Cell. 2018 Jan 4;69(1):36-47.e7
pubmed: 29249653
Genes Dev. 2017 Jul 1;31(13):1370-1381
pubmed: 28790157
EMBO J. 2021 Apr 1;40(7):e106018
pubmed: 33634895
Nat Commun. 2018 Dec 18;9(1):5376
pubmed: 30560944
EMBO Rep. 2019 Sep;20(9):e47250
pubmed: 31338941
Eur J Biochem. 2002 Jan;269(2):583-92
pubmed: 11856317
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nature. 2014 Jul 17;511(7509):362-5
pubmed: 24896180
Cancer Res. 2013 Jan 1;73(1):265-75
pubmed: 23108138
Cell. 2018 Oct 4;175(2):558-570.e11
pubmed: 30245011
Mol Cell. 2011 Jun 24;42(6):794-805
pubmed: 21700224
Cell. 2019 Oct 17;179(3):604-618
pubmed: 31607512
Life Sci Alliance. 2020 Aug 3;3(10):
pubmed: 32747416
Cell. 2016 Nov 3;167(4):1001-1013.e7
pubmed: 27881299
EMBO J. 2019 Aug 1;38(15):e100986
pubmed: 31267554
Elife. 2016 Aug 23;5:
pubmed: 27552054
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18475-80
pubmed: 20937877
Mol Cell. 2016 Jul 7;63(1):167-78
pubmed: 27373332
Nat Commun. 2016 Sep 15;7:12813
pubmed: 27628236
Biomol NMR Assign. 2020 Apr;14(1):79-85
pubmed: 31900740
Oncogene. 2013 Jul 18;32(29):3461-9
pubmed: 22986526
Cancer Res. 2017 Jun 1;77(11):2789-2799
pubmed: 28283652
Mol Cell. 2014 Dec 18;56(6):777-85
pubmed: 25435140
Nat Protoc. 2019 Jun;14(6):1734-1755
pubmed: 31053798
Cancer Res. 1999 Aug 1;59(15):3547-51
pubmed: 10446958
Cancer Res. 2008 Jul 1;68(13):5023-30
pubmed: 18593900
Nucleic Acids Res. 2014 Aug;42(14):9047-62
pubmed: 25030905
Cell Res. 2009 Dec;19(12):1388-400
pubmed: 19786986
Nat Cell Biol. 2012 Feb 19;14(3):318-28
pubmed: 22344029
Mol Cell Biol. 2016 Oct 28;36(22):2794-2810
pubmed: 27550810
Mol Cell. 2015 Feb 19;57(4):636-647
pubmed: 25699710
Nat Commun. 2016 Oct 11;7:13087
pubmed: 27725641
Proteomics. 2007 Aug;7(15):2553-6
pubmed: 17610305
Mol Cell. 2015 Nov 5;60(3):351-61
pubmed: 26593718
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell. 2017 Jun 1;169(6):1105-1118.e15
pubmed: 28575672
Genes Dev. 2019 Aug 1;33(15-16):1008-1026
pubmed: 31123061
Cancer Discov. 2012 Sep;2(9):812-25
pubmed: 22750847
J Cell Biol. 2006 Apr 24;173(2):195-206
pubmed: 16618811
Nat Commun. 2020 Apr 14;11(1):1819
pubmed: 32286328
RNA. 2017 Jul;23(7):1125-1138
pubmed: 28411202
Cell. 2011 May 13;145(4):529-42
pubmed: 21565612
Nat Struct Mol Biol. 2017 May 4;24(5):439-443
pubmed: 28471430
Nat Commun. 2018 Feb 7;9(1):532
pubmed: 29416038
J Cell Biol. 2017 Dec 4;216(12):4007-4026
pubmed: 29030393
Science. 2004 Oct 29;306(5697):876-9
pubmed: 15375219
Nature. 2012 Aug 9;488(7410):231-5
pubmed: 22722852
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nature. 2010 Oct 7;467(7316):678-83
pubmed: 20729832
Mol Cell Proteomics. 2005 Sep;4(9):1265-72
pubmed: 15958392
Nature. 1989 Jun 15;339(6225):562-4
pubmed: 2471939
J Immunol Methods. 1986 May 1;89(1):123-30
pubmed: 2422282
Nat Struct Mol Biol. 2014 Apr;21(4):366-74
pubmed: 24658350
Cell. 2009 Mar 20;136(6):1032-43
pubmed: 19303847
Wiley Interdiscip Rev RNA. 2019 Mar;10(2):e1519
pubmed: 30506978
Mol Cell Biol. 1991 Mar;11(3):1326-33
pubmed: 1996094
Mol Cell. 2016 Oct 20;64(2):388-404
pubmed: 27768874
PLoS Genet. 2015 Nov 19;11(11):e1005674
pubmed: 26584049
Mol Cell Biol. 2008 Oct;28(20):6413-25
pubmed: 18710941
Nat Commun. 2018 Feb 7;9(1):533
pubmed: 29416069
EMBO J. 2017 May 2;36(9):1182-1198
pubmed: 28314779

Auteurs

Gaetana Sessa (G)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Belén Gómez-González (B)

Andalusian Molecular Biology and Regenerative Medicine Centre-CABIMER, University of Seville-CSIC, Seville, Spain.
Departamento de Genética, Facultad de Biología, University of Seville, Seville, Spain.

Sonia Silva (S)

Andalusian Molecular Biology and Regenerative Medicine Centre-CABIMER, University of Seville-CSIC, Seville, Spain.
Departamento de Genética, Facultad de Biología, University of Seville, Seville, Spain.

Carmen Pérez-Calero (C)

Andalusian Molecular Biology and Regenerative Medicine Centre-CABIMER, University of Seville-CSIC, Seville, Spain.
Departamento de Genética, Facultad de Biología, University of Seville, Seville, Spain.

Romane Beaurepere (R)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Sonia Barroso (S)

Andalusian Molecular Biology and Regenerative Medicine Centre-CABIMER, University of Seville-CSIC, Seville, Spain.
Departamento de Genética, Facultad de Biología, University of Seville, Seville, Spain.

Sylvain Martineau (S)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Charlotte Martin (C)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Åsa Ehlén (Å)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Juan S Martínez (JS)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Bérangère Lombard (B)

Laboratoire de Spectrométrie de Masse Protéomique, Institut Curie, PSL Research University, Paris, France.

Damarys Loew (D)

Laboratoire de Spectrométrie de Masse Protéomique, Institut Curie, PSL Research University, Paris, France.

Stephan Vagner (S)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Andrés Aguilera (A)

Andalusian Molecular Biology and Regenerative Medicine Centre-CABIMER, University of Seville-CSIC, Seville, Spain.
Departamento de Genética, Facultad de Biología, University of Seville, Seville, Spain.

Aura Carreira (A)

Institut Curie, Université PSL, CNRS UMR3348, Orsay, France.
Université Paris-Saclay, CNRS UMR3348, Orsay, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH